
Syed Arif Ahmad MD
Surgical Oncology (Other than Breast)
Director University of Cincinnati Cancer Center
Join to View Full Profile
3199 Highland AveCincinnati, OH 45219
Phone+1 513-584-8900
Fax+1 513-584-0459
Dr. Ahmad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Syed Ahmad is the Director of the University of Cincinnati Cancer Center and Chief of Surgical Oncology at the University of Cincinnati, He received his medical degree from University of Maryland School of Medicine and has been in practice 25 years. He specializes in surgical oncology (other than breast) and is experienced in surgical oncology (non-breast), general / gastrointestinal surgery, and hepatopancreatobiliary surgery.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2000
University of Pennsylvania Health SystemResidency, Surgery, 1992 - 1998
University of Maryland School of MedicineClass of 1992
Duke UniversityB.S., Zoology, 1984 - 1988
Certifications & Licensure
OH State Medical License 2001 - 2027
TX State Medical License 1998 - 2001
PA State Medical License 1993 - 1998
MD State Medical License 1995 - 1996
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctor Cincinnati Magazine, 2009, 2011-2016
- Best Doctors in America Cincy Magazine, 2008-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- Updates on Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma.Gregory C Wilson, Sameer H Patel, Syed A Ahmad
Hematology/oncology Clinics of North America. 2026-02-01 - Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma.Benjamin A Y Cher, Christopher J Zimmermann, Juan G Favela, Linda C Stafford, Daniel Bolt
HPB. 2025-11-01 - Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer.Mary P Martos, Erin M Dickey, Kawther Abdilleh, Syed A Ahmad, Shishir K Maithel
Cancer. 2025-11-01
Journal Articles
- In‐Hospital and 90‐Day Outcomes After Total Pancreatectomy with Islet Autotransplantation for Pediatric Chronic and Acute Recurrent PancreatitisJoyce Slusher, Jaimie D Nathan, Tom K Lin, Syed Ahmad, Stephen M Ogg, Lori A Aronson, Ranjit Chima, Kenneth R Goldschneider, John Rose, John Brunner, Deborah A Elder, ..., American journal of transplantation
- Perioperative Net Fluid Balance Predicts Pancreatic Fistula After PancreaticoduodenectomyTiffany C Lee, Mackenzie C Morris, Shimul A Shah, Syed A Ahmad, Journal of gastrointestinal surgery
- Reply to Letter: "Factors Influencing Readmission After Pancreaticoduodenectomy: A Multi-Institutional Study of 1302 Patients"Sutton JM, Ahmad SA, Ann Surg, 11/18/2013
- Join now to see all
Press Mentions
HMN 2025: How Cellular Targets to Overcome KRAS Inhibitor Resistance in Pancreatic Tumors IdentifiedDecember 4th, 2025
How Can I Reduce My Risk of Cancer?April 15th, 2025
Family Invests in Cancer Research to Honor CincinnatianNovember 21st, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









